
Ion Robotic Bronchoscopy | Intuitive
4 天之前 · We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when lung nodules are small and located in the periphery. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung with more reach, precision, and stability. 1
U. S. FDA Grants Clearance for Ion by Intuitive
SUNNYVALE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) cleared the Ion ™ endoluminal system to enable minimally invasive biopsy in the ...
The Ion Endoluminal System (Ion) from Intuitive, a global technology leader in minimally invasive care, could help improve precision when taking tissue biopsies of lung nodules, meaning patients could get diagnoses much faster. Ion uses unique shape-sensing technology and robotic-assistance to enable clinicians to access deep,
Intuitive Announces FDA Clearance of Fifth-Generation Robotic …
SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) provided 510 (k) clearance for da Vinci 5, the company’s next-generation multiport robotic system.
Intuitive Ion wins regulatory approval in China - MassDevice
2024年3月21日 · Intuitive Surgical (Nasdaq:ISRG) has received approval from regulatory authorities in China to market its Ion surgical robot system.
Intuitive Surgical's (ISRG) Ion System Backed by Clinical Study
2021年10月20日 · Intuitive Surgical, Inc. ISRG recently released preliminary data from the Prospective, Multi-Center Evaluation of the Clinical Utility (PRECIsE) study — a post-market, multi-center clinical trial...
强强联合!机器人龙头+影像大佬 - 知乎 - 知乎专栏
2022年6月30日,Intuitive (Nasdaq: ISRG)与西门子医疗(OTC PINK: SMMNY、SEMHF、FWB: SHL)共同宣布美国食品和药品监督管理局(FDA)已批准将Intuitive的Ion平台与西门子的Cios Spin移动锥形束CT(CBCT)成像技术集成。
【猛兽财经】直觉外科公司(ISRG):手术机器人领域的龙头企 …
Intuitive Surgical (以下简称“直觉外科公司”,股票代码:ISRG)是一家美国的医疗技术公司,开发和制造机器人辅助手术的机器人产品。 它的旗舰产品是一款名为“da Vinci(达芬奇)”的机器人系统。
ISRG将光纤形状传感应用于经自然腔道手术机器人_武汉从时光瑞 …
2024年1月29日 · ISRG是将光纤形状传感(FOSS)应用于经自然腔道手术机器人的先行者。 其Ion微创支气管镜系统,凭借FOSS技术在活检过程中获得导管的精确位置和形状信息。 光纤形状传感,绝不会局限于一个医疗机器人赛道! 从LUNA到ISRG,TRSN在学习,在思考,在前进! ISRG是将光纤形状传感(FOSS)应用于经自然腔道手术机器人的先行者。 其Ion微创支气管镜系统,凭借FOSS技术在活检过程中获得导管的精确位置和形状信息。 光纤形状传感,绝不会局 …
2024年医疗行业直觉外科(ISRG)专题报告:手术革命发起者,全 …
2024年1月8日 · 直觉外科拓领域的一款重磅产品——支气管镜机器人Ion:常规支气管镜所及检查范围有限,且风险较高,Ion机器人可到达极细支气 管,可触及检测区域增加。
- 某些结果已被删除